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496a Tuesday, February 23, 2010Methods: DRG from newborn Wistar rats were treatead with trypsin and me-
chanically dissociated. The cells were cultivated on poli-L-lysine-treated glass
slips. The culture was kept in DMEM with 5% fetal bovine serum, at 37C and
under 5% CO2 atmosphere. Changes in intracellular free-Ca2þ concentration
([Ca2þ]i) were evaluted in a confocal laser scanning microscope (Zeiss, LSM
510), using Fluo-4 (Molecular Probes) as a calcium indicator. Time series were
recorded in control conditions and during the exposure to the putative agonist.
Results: ATP 0.1 mM promoted transitory increases in the [Ca2þ]i in SGC
(94.4%, n=18) even in free-Ca2þ medium (81,3%, n=32). The P2Y agonists
ADP 0.1 mM, UTP 1 mM and UDP 1 mM promoted oscillations in 93.1%
(n=54), 15.6% (n=32) and 38.1% (n=42) of the SGC, respectively. Like
ADP, the MRS2365 0.1 mM, a selective P2Y1 agonist, promoted Ca2þ in-
crease (91.6 %, n=12). Previous application of MRS2365 blunts the response
of the SGC to BzATP 25mM (n=6), an agonist of P2X7 receptor.
Conclusions: The SGC from DRG express P2Y and P2X7 receptors. The ADP
sensitive subtype (P2Y1) predominates. A fraction of the observed SGC ex-
presses the UDP sensitive subtype (P2Y6), and a yet smaller fraction expresses
the UTP sensitive subtype (P2Y2 and/or P2Y4). Previous activation of the
P2Y1 receptor drastically reduces cell responses to BzATP, probably by down-
regulation of P2X7 ionotropic receptor.
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Glycogen Synthase Kinase 3-b (GSK3-b) is a negative regulator for cardiac hy-
pertrophy. This kinase controls protein synthesis mainly via activation of both
the translation initiation factor eIF2Be and the transcription factor NFAT. Tes-
tosterone induces cardiomyocyte hypertrophy, but if GSK3-b participates in
this event is unknown. Here we have studied whether the inhibition of
GSK3-b is involved in testosterone-induced cardiac hypertrophy.
Testosterone (100 nM) inhibited GSK3-b (phosphorylation increase at Ser9)
and activated the factor eIF2Be (phosphorylation decrease at Ser539). More-
over, pharmacological inhibition of GSK3-b by 1-azakenpaullone (10 mM) in-
creases the hormone-induced eIF2Be activation.
GSK3-b inhibition can be mediated by PI3K/Akt or MEK/ERK1/2 pathways.
PI3K/Akt inhibitors LY-292002 (1 mM) and Akt-inhibitor-VIII (10 mM)
blocked the testosterone-induced GSK3-b phophorylation, whereas ERK1/2 in-
hibitor (PD98059 50 mM) had not effect. NFAT is well characterized down-
stream target for GSK3-b. Testosterone increased the NFAT-luc activity and
this was blocked by NFAT inhibitors CsA (1 mM) and FK506 (1 mM). More-
over, GSK3-b inhibition increased NFAT activity.
In order to investigate the GSK3-b/NFAT contribution to testosterone-induced
hypertrophy, we evaluate the expression of skeletal a-actin (SKA). Testoster-
one and 1-azakenpaullone increased SKA expression while NFAT inhibition
blocked the testosterone-induced SKA increases.
These results suggest that testosterone-induced cardiomyocyte hypertrophy in-
volves inhibition of GSK3-b through PI3K/Akt pathway and activation of both
NFAT and eIF2Be.
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Extracts of Echinacea plants induce intense tingling paresthesia and numbing
analgesia when applied orally. Currently, there is little information regarding
the cellular or molecular mechanisms by which Echinacea produces its somato-
sensory effects. We characterized the ability of Echinacea extracts to activate
somatosensory neurons in vitro. Crude extracts induce a rise in intracellular cal-
cium in a subset of somatosensory neurons (49.056.2%), as measured by ra-
tiometric calcium imaging. In addition, application of Echinacea extract during
whole-cell current-clamp recording triggers depolarization of the resting mem-
brane potential, followed by action potential firing. Both the crude extract and
the purified alkylamide, Dodeca-2E, 4E- dienoic acid isobutylamide (E2), ac-
tivate a unique subset of somatosensory neurons that includes a large popula-
tion of putative light touch receptors. Whole-cell voltage clamp recording
shows that E2 blocks a background potassium current (28.053.8% inhibition
at 50mV; reversal potential¼51.8,52.5), in 56% of somatosensory neurons.
Interestingly, we find that E2 also inhibits voltage gated sodium currents in
57% of neurons (44.655.1% inhibition at x 20mV). We propose a model
in which Dodeca-2E, 4E- dienoic acid isobutylamide induces tingling paresthe-sia by inhibition of background potassium currents and numbing analgesia by
blocking voltage-gated sodium channels.
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We reported that attachment of atrial myocytes to laminin (LMN) decreases ad-
enylate cyclase (AC)/cAMP and increases b2-AR stimulation of L-type Ca
2þ
current (ICa,L). This study determined whether LMN enhances b2-AR signaling
via a cAMP-independent mechanism, i.e. cPLA2 signaling. Atrial myocytes
were plated on uncoated cover-slips (-LMN) or cover-slips coated with LMN
(þLMN) (>2 hrs). As previously reported, 0.1 mM zinterol (b2-AR agonist)
stimulation of ICa,L was larger in þLMN than -LMN myocytes. In þLMN my-
ocytes, zinterol stimulation of ICa,L was inhibited by 10 mM AACOCF3 (cPLA2
inhibitor), pertussis toxin or 10 mM BAPTA-AM (intracellular Ca2þ chelator).
Stimulation of ICa,L by fenoterol (b2-AR/Gs agonist) was smaller in þLMN
than -LMN myocytes. Arachidonic acid (AA; 5 mM) stimulated ICa,L
in -LMN and þLMN myocytes similarly. Inhibition of PKA by either 5 mM
H-89 or 1 mM KT5720 in -LMN myocytes mimicked the effects of þLMN
myocytes to enhance zinterol stimulation of ICa,L, which was blocked by
AACOCF3. In contrast, H-89 inhibited fenoterol stimulation of ICa,L, which
was unchanged by AACOCF3. Inhibition of ERK1/2 by 1 mM U-0126 inhibited
zinterol stimulation of ICa,L in þLMN myocytes and -LMN myocytes in which
PKA was inhibited (KT5720). Western blots showed that inhibition of PKA
(KT5720) in -LMN myocytes markedly increased zinterol phosphorylation of
ERK1/2. We conclude that inhibition of AC/cAMP/PKA by cell attachment
to LMN or PKA by pharmacological agents in -LMN myocytes switches
b2-AR signaling from predominantly Gs/AC/cAMP/PKA to Gi/ERK1/2/
cPLA2/AA. These findings may be relevant to the remodeling of b-AR signal-
ing in diseased (fibrotic) and/or aging atria, both of which exhibit decreases in
AC activity.
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We reported that inhibition of adenylate cyclase (AC)/cAMP by cell attachment
to laminin (þLMN) or pharmacological (KT5720) inhibition of cAMP-depen-
dent protein kinase (PKA) in cells not attached to LMN (-LMN-PKA), activates
b2-AR stimulation of ICa,L via cPLA2 signaling. The present study determined
the role of PKC and IP3-mediated Ca
2þ release in b2-AR/cPLA2 signaling. As
previously reported, 0.1 mM zinterol (b2-AR agonist) stimulation of L-type
Ca2þ current (ICa,L) was unaffected by 10 mM AACOCF3 (cPLA2 inhibitor) in
cells not attached to LMN (-LMN) but was significantly inhibited in þLMN
and -LMN-PKA myocytes. Zinterol stimulation of ICa,L in -LMN
-PKA myocytes
was blocked by 5 mM U73122 (PLC inhibitor) and significantly inhibited by
4 mM chelerythrine (PKC inhibitor). Zinterol stimulation of ICa,L in -LMN my-
ocytes was unaffected by inhibition of IP3-receptors (IP3Rs) by 2 mM 2-APB, but
was significantly inhibited inþLMN and -LMN-PKA myocytes. Cells were cul-
tured on LMN (24 hrs) with an adenovirus IP3 affinity trap to inhibit IP3-depen-
dent Ca2þ signaling. Compared to control cells (b-gal), zinterol stimulation of
ICa,L was significantly inhibited in cells infected with IP3 trap. Laser scanning
confocal microscopy (fluo-4) revealed that zinterol stimulation ofþLMN myo-
cytes elicited local intracellular Ca2þ release events in 1 mM tetracaine (blocks
RyR Ca2þ release), that were blocked by 2-APB. We conclude that inhibition of
cAMP/PKA activates b2-AR stimulation of ICa,L via cPLA2 which is dependent
on PKC and IP3-mediated Ca
2þ signaling. These findings may be relevant to the
remodeling of b-AR signaling in diseased (fibrotic) and/or aging atria, both of
which exhibit decreases in AC activity.
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Adenosine is a candidate modulator of motility of spermatozoa as they progress
through the female reproductive tract. Past work demonstrated that the adenosine
analog 2-chloro-deoxyadenosine (Cl-dAdo) accelerates the flagellar beat rate of
